Business
Ainos Reports First Quarter 2025 Financial Results
Q1 revenues increased 412% year over year, driven by AI Nose products Delivers strong turnaround from gross loss to gross profit in Q1 AI Nose gains traction beyond healthcare with strategic partnerships in robotics and semiconductor sectors VELDONA® ...
About this update from Ainos, Inc.
[{"type":"text","content":"Q1 revenues increased 412% year over year, driven by AI Nose products","length":69,"tagName":"p"},{"type":"text","content":"Delivers strong turnaround from gross loss to gross profit in Q1","length":64,"tagName":"p"},{"type":"text","content":"AI Nose gains traction beyond healthcare with strategic partnerships in robotics and semiconductor sectors","length":106,"tagName":"p"},{"type":"text","content":"VELDONA® program advances with TFDA and IRB Approvals for two clinical trials in Taiwan","length":95,"tagName":"p"},{"type":"text","content":"SAN DIEGO, CALIFORNIA / ACCESS Newswire / May 12, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company") today announced its financial results for the first quarter ended March 31, 2025.","length":226,"tagName":"p"},{"type":"text","content":"Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "Q1 2025 represents a significant step forward in advancing our long-term strategy to build a differentiated healthcare and technology company powered by scent digitization, AI-enhanced diagnostics and innovative therapeutics. Revenues increased 412% year over year, primarily driven by sales of AI Nose products for elderly care under the Nisshinbo Micro Devices Inc. ("NISD") co-development project. This performance is a testament to the growing commercial viability of our proprietary AI Nose technology in healthcare."","length":650,"tagName":"p"},{"type":"text","content":""While our AI Nose technology has a deep root in healthcare use-case, we are expanding the application scope into the robotics and industrial sectors. We've made rapid progress in establishing strategic partnerships, including collaborations with a leading Japanese service robot developer to embed AI Nose into robots, and with the world's largest semiconductor packaging and testing provider to deploy AI Nose in semiconductor manufacturing environments. "","length":476,"tagName":"p"},{"type":"text","content":""Rising AI integration across industries validates our strategic direction. The global electronic nose market is projected to grow from $29.8 billion in 2025 to $76.5 billion by 2032. Demand is rising across healthcare, environmental, and industrial sectors-precisely where our AI Nose is g...